• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. APTIMA CV/TV ASSAY; VAGINITIS AND BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. APTIMA CV/TV ASSAY; VAGINITIS AND BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM Back to Search Results
Catalog Number PRD-05189
Device Problem Erratic Results (4059)
Patient Problem Insufficient Information (4580)
Event Date 11/30/2023
Event Type  Injury  
Event Description
On 12/08/2023, a customer reported to hologic that they had one discrepant acv/tv sample run on their panther fusion plus instrument.The sample was initially tested on (b)(6) 2023 using assay lot 884972 and resulted positive for trichomonas vaginalis (tv).The customer site has an internal protocol to retest any tv-positive samples.When the sample was retested on (b)(6) 2023 using assay lot 884972, the sample resulted negative for tv.The customer confirmed that the negative result was reported to the patient.There was no information provided by the customer about any patient impact or treatment provided to the patient.
 
Manufacturer Narrative
Hologic technical support (ts) reviewed the instrument logs.Both the initial and retest runs were valid and had no hardware or reagent preparation issues identified.In the first run, the sample in question was among several negative samples.Ts suggested the affected sample could have had low target or was mishandled.Customer understood the log review and reported no further issues.Hologic completed a risk assessment.No serious injury has been reported to hologic in association with this issue.The aptima cv/tv assay package insert limitations states that ¿results from the aptima cv/tv assay should be interpreted in conjunction with other clinical data available to the clinician.¿ in addition, the ¿[u]se of this assay is limited to personnel who have been trained in the procedure.Failure to follow the instructions given in this package insert may result in erroneous results.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
APTIMA CV/TV ASSAY
Type of Device
VAGINITIS AND BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM
Manufacturer (Section D)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center drive
san diego CA 92121
Manufacturer Contact
kyleigh jacobs
10210 genetic center drive
san diego, CA 92121
8584108566
MDR Report Key18460524
MDR Text Key332262983
Report Number2024800-2024-00001
Device Sequence Number1
Product Code PQA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190472
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberPRD-05189
Device Lot Number884972
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2023
Initial Date FDA Received01/05/2024
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Other;
-
-